Morgan Stanley continued its impressive climb this week, closing at $189.31 on April 21, up 3.3% over the past seven days. The investment bank has now gained 17.2% over the past month, significantly outperforming the broader financial sector.
The stock's technical strength is evident. RSI sits at 69.6, approaching overbought territory but reflecting genuine bullish momentum. ORTEX Stock Scores paint a favorable picture, with a total score of 90.2 as of April 21. The bank scores particularly well on value (75.9) and momentum (76.7) metrics.
Short interest remains minimal at just 1.02% of free float. The 16.3 million shares short represent barely two days of average trading volume, providing little fuel for any squeeze scenario. Cost to borrow edged up 9.3% over the week to 0.36%, while utilization held steady at 0.8% — both levels reflecting minimal shorting pressure.
The options market tells a more nuanced story. Put-call ratio jumped to 1.466, well above the 20-day average of 1.38. The PCR's z-score of 2.22 suggests elevated hedging activity, potentially indicating some caution despite the recent rally. Still, this hasn't derailed the upward price trend.
Morgan Stanley reported Q1 earnings on April 15, beating expectations. The next earnings event is scheduled for May 14. With analyst return potential at 4.5% and a forward yield of 2.3%, the stock combines growth prospects with modest income.
The bank's forward P/E remains attractive within the capital markets sector, supported by strong return on equity and robust cash generation. Quality scores above 72 reflect solid fundamentals backing the recent price strength.
This is not financial advice. Data is provided for informational purposes and may contain errors.
See the live data behind this article on ORTEX.
Open MS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
